Hosted on MSN
Hinge Health forecasts $798M-$804M 2026 revenue while launching FDA-cleared Enso migraine program
CEO Daniel Perez said, "We delivered strong results across all key financial metrics this quarter, outperforming our expectations and demonstrating the continued strength of our business," and ...
A 12-week, 177-participant trial of Hinge Health’s at-home digital program for chronic pain relief significantly reduced users’ lower back pain, disability and interest in surgery. The study, led by ...
Cleared by the FDA for migraine, Hinge Health’s Enso® delivers on-demand pain relief Already 125+ clients covering more than two million people have adopted the Migraine Care Program SAN ...
Older adults used a digital musculoskeletal (MSK) program more often than younger generations, according to a study published in Frontiers in Digital Health. The study used Hinge Health’s Digital ...
CFO James Budge guided, "For Q2 2026, we expect revenue to be in the range of $194 million to $196 million" and "for income from operations, we're projecting $47 million to $49 million for the second ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results